A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma
- 23 July 2010
- journal article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 19 (5) , 365-372
Abstract
The purpose of this study was to prepare a pressure-controlled colon delivery capsule (PCDC) containing theophylline (TPH) dispersion in a lipid matrix as a chronotherapeutic drug delivery system for the treatment of nocturnal asthma. The system was made by film coating using Eudragit S100- based formula over the sealed-hard gelatin capsules containing the drug-lipid dispersion. The lipid formula was composed mainly of Gelucire 33/01 (G33) with different ratios of surfactants (1–10%). The efficiency of the prepared system was evaluated in vitro for its ability to withstand both the gastric and intestinal medium. In addition, the drug plasma concentrations were monitored after single administration to Beagle dogs and compared to that obtained after administration of a reference marketed, generic, sustained-release TPH tablets, Avolen® SR. It was found that the optimum lipid formula was GL2 containing 90% G33 and 10% Labrasol. The film-coated capsules showed complete resistance to both the acidic environment (pH 1.2) for 2 hours and phosphate buffer pH 6.8 for 3 hours at 37°C. In vivo evaluation of the TPH-based PCDCs showed longer lag time compared TO the marketed formula followed by sudden increase in TPH blood levels, which recommends the high potential of this system as a chronotherapeutic drug delivery for nocturnal asthma. The prepared PCDCs exhibited a significantly higher Cmax and Tmax and a nonsignificantly different AUC compared with Avolen® SR. Higher TPH blood levels from 1 to 8 hours postadministration was detected in the case of the prepared PCDCs.Keywords
This publication has 46 references indexed in Scilit:
- Preparation and Characterization of Spironolactone-Loaded Gelucire Microparticles Using Spray-Drying TechniqueDrug Development and Industrial Pharmacy, 2009
- Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatingsJournal of Controlled Release, 2008
- Etodolac-Liquid-Filled Dispersion into Hard Gelatin Capsules: An Approach to Improve Dissolution and Stability of Etodolac FormulationDrug Development and Industrial Pharmacy, 2006
- Calcium Pectinate Capsules for Colon-Specific Drug DeliveryDrug Development and Industrial Pharmacy, 2005
- Development of Enteric-coated Timed-release Matrix Tablets for Colon TargetingJournal of Drug Targeting, 2004
- Semisolid Matrix Filled Capsules: An Approach to Improve Dissolution Stability of Phenytoin Sodium FormulationDrug Development and Industrial Pharmacy, 2003
- It's time for chronotherapy!European Journal of Cancer, 2002
- Comparison of the release profiles of a water soluble drug carried by Eudragit-coated capsules in different in-vitro dissolution liquidsPowder Technology, 2001
- Characterization of Norfloxacine Release from Tablet Coated with a New pH-Sensitive Polymer, P-4135FJournal of Drug Targeting, 1999
- Comparison of Effects of Controlled Onset Extended Release Verapamil at Bedtime and Nifedipine Gastrointestinal Therapeutic System on Arising on Early Morning Blood Pressure, Heart Rate, and the Heart Rate–Blood Pressure Product11A list of study investigators appears in the Appendix A.The American Journal of Cardiology, 1998